Patent

USA PATENT RECENTLY GRANTED!

ARP’s commitment to developing and protecting the 4JOINTZ® technology is evidenced by its intellectual property (IP) portfolio including Patents, Trademarks (4JOINTZ®) and Clinical Trials.

To date, the 4JOINTZ® patent has been successfully granted in USA, Australia, China, Japan, Malaysia, New Zealand, Russia Federation and Singapore.

The patent specification covers both composition of matter and method of use claims.